tiprankstipranks
AIM ImmunoTech Inc (AIM)
NYSE MKT:AIM

AIM ImmunoTech (AIM) Financial Statements

826 Followers

AIM ImmunoTech Financial Overview

AIM ImmunoTech's market cap is currently ―. The company's EPS TTM is $-0.635; its P/E ratio is -0.58; AIM ImmunoTech is scheduled to report earnings on August 13, 2024, and the estimated EPS forecast is $-0.12. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 46.00K$ 42.00K$ 49.00K$ 57.00K$ 21.00K
Gross Profit$ 16.00K$ 42.00K$ 49.00K$ 203.00K$ 21.00K
EBIT$ -8.16M$ -5.24M$ 4.77M$ -5.00M$ -6.38M
EBITDA$ -8.10M$ -5.16M$ 4.82M$ -4.83M$ -6.36M
Net Income Common Stockholders$ -7.82M$ -4.91M$ 5.03M$ -4.39M$ -6.38M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 22.43M$ 28.40M$ 30.85M$ 34.19M$ 36.74M
Total Assets$ 27.86M$ 33.62M$ 37.31M$ 40.49M$ 46.28M
Total Debt$ 750.00K$ 803.00K$ 814.00K$ 837.00K$ 866.00K
Net Debt$ -21.68M$ -27.59M$ -30.04M$ -33.35M$ -35.88M
Total Liabilities$ 5.26M$ 3.48M$ 2.47M$ 2.02M$ 3.59M
Stockholders Equity$ 22.60M$ 30.14M$ 34.99M$ 38.47M$ 42.70M
Cash Flow-
Free Cash Flow$ -6.05M$ -2.21M$ -3.63M$ -2.64M$ -4.99M
Operating Cash Flow$ -5.67M$ -2.16M$ -3.66M$ -6.07M$ -4.97M
Investing Cash Flow$ -336.00K$ -204.00K$ -78.00K$ 3.36M$ 250.00K
Financing Cash Flow$ 233.00K$ 5.00K$ 100.00K-$ 25.00K
Currency in USD

AIM ImmunoTech Earnings and Revenue History

AIM ImmunoTech Debt to Assets

AIM ImmunoTech Cash Flow

AIM ImmunoTech Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis